comparemela.com

Latest Breaking News On - Ronald ackermann - Page 1 : comparemela.com

Nearly 40% of Type 2 diabetes patients stop taking their second-line medication

Nearly 40% of Type 2 diabetes patients stop taking their second-line medication
insurancenewsnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insurancenewsnet.com Daily Mail and Mail on Sunday newspapers.

Nearly 40% of type 2 diabetes patients stop taking their second-line medication, finds study

Nearly 40% of type 2 diabetes patients stop taking their second-line medication, finds study
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Nearly 40% of Type 2 diabetes patients stop t

<p>Most patients with Type 2 diabetes will end up needing to add a second-line medication after metformin &mdash; the go-to primary drug for glucose management &mdash; to control their blood sugar levels. But adherence to these second-line drugs can be hit or miss, reports a new Northwestern Medicine study.&nbsp;&nbsp;Among patients prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs), half (50%) discontinued treatment.&nbsp;</p>

Nearly 40% of Type 2 diabetes patients stop taking their second-line medication

Nearly 40% of Type 2 diabetes patients stop taking their second-line medication
sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.

Use age, not weight, to screen for diabetes: Age will capture the greatest proportion of adults with prediabetes and diabetes

Use age, not weight, to screen for diabetes: Age will capture the greatest proportion of adults with prediabetes and diabetes
sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.